Back to results
US 2023/0051860 A1Published application
Combination immunotherapies for treatment of cancer
AssigneePrimevax Immuno-Oncology, Inc.
InventorBruce W. LYDAY
Life of this patent
Estimating the term…
Abstract
Described herein are compositions and methods for treating a disease, particularly a cancer, with an immune checkpoint modulatory agent and a strain of an Arbovirus or a strain of an Alphavirus. Also provided herein are also methods for combination therapy comprising administration of an immune checkpoint modulatory agent, tumor antigen primed dendritic cells and an Alphavirus or an Arbovirus.
Claims1
1. A method for treatment or reduction of cancer, comprising administering to a subject in need thereof:
- a) a strain of an Arbovirus or a strain of an Alphavirus;
- and
- b) an immune checkpoint modulatory agent, wherein the administering provides for treatment or reduction of a cancer.
Dependencies are inferred from the claim text.